Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Universitätsklinikum Hamburg-Eppendorf
National Cancer Institute (NCI)